Orthofix Reports Second Quarter 2025 Financial Results
OFIXLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Company’s decision to discontinue its M6® product lines. Highlights Second quarter 2025 net sales of $203.1 million, including sales from M6® artificial cervical and l
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
OFIXLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the TrueLok™ Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented design for use in the TBT procedure to provide a limb preservation treatment option for addressing bony or soft tissue deformities or defects, such as diabetic ulcers. “I have b
JMP Securities Reiterates Market Perform on Orthofix Medicalto Market Perform
OFIXOrthofix Medical Lowers FY2025 Sales Guidance from $818.00M-$826.00M to $808.00M-$816.00M vs $821.98M Est
OFIXOrthofix Medical Q1 Adj. EPS $(0.08) Beats $(0.27) Estimate
OFIXOrthofix Medical Q1 Sales $193.65M Beat $191.10M Estimate
OFIXOrthofix Receives FDA 510(k) Clearance And European CE Mark For The TrueLok Elevate Transverse Bone Transport System
OFIXCanaccord Genuity Maintains Buy on Orthofix Medical, Maintains $24 Price Target
OFIXRoth MKM Reiterates Buy on Orthofix Medical, Maintains $22 Price Target
OFIXOrthofix Medical Sees FY2025 Sales $818.000M-$826.000M vs $847.01M Est
OFIXOrthofix Medical Q4 Adj $0.02 Beats $(0.05) Estimate, Sales $215.66M Beat $212.71M Estimate
OFIXOrthofix Medical Announces FDA Pre-market Approval For The AccelStim Bone Healing Therapy Class III Device
OFIXOrthofix and MTF Biologics Expand Partnership Agreement
OFIXOrthofix Medical Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET
OFIXOrthofix Medical (NASDAQ:OFIX) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results.
How to Attend Orthofix Medical (OFIX) Conference Call
Follow this link to access the live webcast.
